These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21227275)

  • 1. Catecholamine modulation of prefrontal cortical cognitive function.
    Arnsten AF
    Trends Cogn Sci; 1998 Nov; 2(11):436-47. PubMed ID: 21227275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF
    CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.
    Xing B; Li YC; Gao WJ
    Brain Res; 2016 Jun; 1641(Pt B):217-33. PubMed ID: 26790349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons.
    Chandler DJ; Waterhouse BD; Gao WJ
    Front Neural Circuits; 2014; 8():53. PubMed ID: 24904299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.
    Arnsten AF
    Cereb Cortex; 2007 Sep; 17 Suppl 1():i6-15. PubMed ID: 17434919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine regulation of the prefrontal cortex.
    Arnsten AF
    J Psychopharmacol; 1997; 11(2):151-62. PubMed ID: 9208378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
    Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex.
    Birnbaum S; Gobeske KT; Auerbach J; Taylor JR; Arnsten AF
    Biol Psychiatry; 1999 Nov; 46(9):1266-74. PubMed ID: 10560032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
    Brennan AR; Arnsten AF
    Ann N Y Acad Sci; 2008; 1129():236-45. PubMed ID: 18591484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortex.
    Berridge CW; Spencer RC
    Brain Res; 2016 Jun; 1641(Pt B):189-96. PubMed ID: 26592951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Pliszka SR
    Biol Psychiatry; 2005 Jun; 57(11):1385-90. PubMed ID: 15950012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic pharmacology and cognition: focus on the prefrontal cortex.
    Ramos BP; Arnsten AF
    Pharmacol Ther; 2007 Mar; 113(3):523-36. PubMed ID: 17303246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.
    Gamo NJ; Arnsten AF
    Behav Neurosci; 2011 Jun; 125(3):282-96. PubMed ID: 21480691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.
    Arnsten AF; Li BM
    Biol Psychiatry; 2005 Jun; 57(11):1377-84. PubMed ID: 15950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.
    Arnsten AF
    J Pediatr; 2009 May; 154(5):I-S43. PubMed ID: 20596295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.